{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:49:57Z","timestamp":1769086197736,"version":"3.49.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1097\/ico.0b013e318158f6ad","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T03:08:32Z","timestamp":1236222512000},"page":"70-73","source":"Crossref","is-referenced-by-count":59,"title":["Topical Bevacizumab and Ocular Surface Neovascularization in Patients With Stevens-Johnson Syndrome"],"prefix":"10.1097","volume":"27","author":[{"given":"Harvey S","family":"Uy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pik Sha","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert Edward","family":"Ang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210204","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0161-6420(95)30811-1","article-title":"Analysis of the acute manifestations of erythema multiforme\/Stevens-Johnson syndrome\/toxic epidermal necrolysis disease spectrum.","volume":"102","author":"Power","year":"1995","journal-title":"Ophthalmology"},{"key":"R2-11-20210204","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0161-6420(94)31138-9","article-title":"Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies.","volume":"101","author":"Maguire","year":"1994","journal-title":"Ophthalmology"},{"key":"R3-11-20210204","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1542-0124(12)70014-9","article-title":"Management of the late ocular sequelae of Stevens-Johnson syndrome.","volume":"1","author":"Wall","year":"2003","journal-title":"Ocul Surf"},{"key":"R4-11-20210204","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ajo.2006.07.055","article-title":"Functional visual acuity in Stevens-Johnson syndrome.","volume":"142","author":"Kaido","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R5-11-20210204","first-page":"283","article-title":"Ophthalmic complications and management of Stevens-Johnson syndrome at a tertiary eye care center in south India.","volume":"50","author":"Kompella","year":"2002","journal-title":"Indian J Ophthalmol"},{"key":"R6-11-20210204","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00003226-198706040-00004","article-title":"Corneal neovascularization. Pathogenesis and inhibition.","volume":"6","author":"Epstein","year":"1987","journal-title":"Cornea"},{"key":"R7-11-20210204","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0161-6420(02)01089-8","article-title":"Transplantation of human limbal stem epithelium cultivated on amniotic membrane for the treatment of severe ocular surface disorders.","volume":"109","author":"Shimazaki","year":"2002","journal-title":"Ophthalmology"},{"key":"R8-11-20210204","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0161-6420(02)01441-0","article-title":"Amniotic membrane transplantation for reconstruction of the conjunctival fornices.","volume":"110","author":"Solomon","year":"2003","journal-title":"Ophthalmology"},{"key":"R9-11-20210204","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/archopht.121.10.1369","article-title":"Amniotic membrane with living related corneal limbal\/conjunctival allograft for ocular surface reconstruction in Stevens-Johnson syndrome.","volume":"121","author":"Gomes","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R10-11-20210204","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ophtha.2003.09.034","article-title":"Punctal occlusion in the management of chronic Stevens-Johnson syndrome.","volume":"111","author":"Kaido","year":"2004","journal-title":"Ophthalmology"},{"key":"R11-11-20210204","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1056\/NEJMoa040455","article-title":"Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium.","volume":"351","author":"Nishida","year":"2004","journal-title":"N Engl J Med"},{"key":"R12-11-20210204","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1136\/bjo.2003.038497","article-title":"Transplantation of cultivated autologous oral mucosal epithelial cells in patients with severe ocular surface disorders.","volume":"88","author":"Nakamura","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R13-11-20210204","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ophtha.2004.11.041","article-title":"Intraoperative mitomycin C and amniotic membrane transplantation for formix reconstruction in several cicatricial ocular surface diseases.","volume":"112","author":"Tseng","year":"2005","journal-title":"Ophthalmology"},{"key":"R14-11-20210204","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1167\/iovs.05-1188","article-title":"The use of autologous serum in the development of corneal and oral epithelial equivalents in patients with Stevens-Johnson syndrome.","volume":"47","author":"Nakamura","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R15-11-20210204","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/bjo.2006.092510","article-title":"Legeais BioKpro III keratoprosthesis implantation: long-term results in seven patients.","volume":"90","author":"Hollick","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R16-11-20210204","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ajo.2006.06.004","article-title":"Ocular surface reconstruction with combination of cultivated autologous oral mucosal epithelial transplantation and penetrating keratoplasty.","volume":"142","author":"Inatomi","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R17-11-20210204","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ajo.2005.03.022","article-title":"Survival analysis of conjunctival limbal grafts and amniotic membrane transplantation in eyes with total limbal stem cell deficiency.","volume":"140","author":"Santos","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R18-11-20210204","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1136\/bjo.86.11.1220","article-title":"Costs and gains of complex procedures to rehabilitate end stage ocular surface disease.","volume":"86","author":"Geerling","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"R19-11-20210204","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization.","volume":"12","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"R20-11-20210204","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1167\/iovs.01-1277","article-title":"VEGF-dependent conjunctivailization of the corneal surface.","volume":"44","author":"Joussen","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-11-20210204","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","article-title":"Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival.","volume":"45","author":"Cursiefen","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R22-11-20210204","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/ICO.0b013e31802b4201","article-title":"Unique homologous siRNA blocks hypoxia-induced VEGF upregulation in human corneal cells and inhibits and regresses murine corneal neovascularization.","volume":"26","author":"Singh","year":"2007","journal-title":"Cornea"},{"key":"R23-11-20210204","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ophtha.2005.02.007","article-title":"Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twelve-week results of an uncontrolled open-label clinical study.","volume":"112","author":"Michels","year":"2005","journal-title":"Ophthalmology"},{"key":"R24-11-20210204","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3928\/1542-8877-20050701-14","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration.","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R26-11-20210204","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjo.2006.107912","article-title":"Inhibition of experimental corneal neovascularization by bevacizumab (Avastin).","volume":"91","author":"Manzano","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R27-11-20210204","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00003226-199109000-00012","article-title":"Photodynamic therapy for corneal neovascularization.","volume":"10","author":"Epstein","year":"1991","journal-title":"Cornea"},{"key":"R28-11-20210204","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/exer.2000.0931","article-title":"Treatment parameters for selective occlusion of experimental corneal neovascularization by photodynamic therapy using a water soluble photosensitizer, ATX-S10 (Na).","volume":"72","author":"Gohto","year":"2001","journal-title":"Exp Eye Res"},{"key":"R29-11-20210204","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00003226-200307000-00018","article-title":"Photodynamic therapy of corneal neovascularization with vertiporfin.","volume":"22","author":"Fossarello","year":"2003","journal-title":"Cornea"},{"key":"R30-11-20210204","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1200\/JCO.2005.10.017","article-title":"Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer.","volume":"23","author":"Hurwitz","year":"2005","journal-title":"J Clin Oncol"},{"key":"R31-11-20210204","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ophtha.2006.10.029","article-title":"New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome.","volume":"114","author":"Sotozono","year":"2007","journal-title":"Ophthalmology"},{"key":"R32-11-20210204","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/01.iae.0000237080.10627.b7","article-title":"Evaluation of anterior chamber inflammatory activity in eyes treated with intravitreal bevacizumab.","volume":"26","author":"Kiss","year":"2006","journal-title":"Retina"},{"key":"R33-11-20210204","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/01.iae.0000230717.85319.f5","article-title":"Safety of intravitreal injection of bevacizumab in rabbit eyes.","volume":"26","author":"Feiner","year":"2006","journal-title":"Retina"},{"key":"R34-11-20210204","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0161-6420(95)30842-1","article-title":"Cytologic evidence of corneal diseases with limbal stem cell deficiency.","volume":"102","author":"Puangsricharern","year":"1995","journal-title":"Ophthalmology"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003226-200801000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:39:52Z","timestamp":1618277992000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-200801000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e318158f6ad","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}